J
Jun Mo
Researcher at Cincinnati Children's Hospital Medical Center
Publications - 6
Citations - 110
Jun Mo is an academic researcher from Cincinnati Children's Hospital Medical Center. The author has contributed to research in topics: Leukemia & Chromosome 7 (human). The author has an hindex of 3, co-authored 6 publications receiving 104 citations.
Papers
More filters
Journal ArticleDOI
Numerical chromosomal changes and risk of development of myelodysplastic syndrome--acute myeloid leukemia in patients with Fanconi anemia.
Parinda A. Mehta,Richard E. Harris,Stella M. Davies,Mi-Ok Kim,Robin Mueller,Beatrice Lampkin,Jun Mo,Kasiani C. Myers,Teresa A. Smolarek +8 more
TL;DR: Children with FA should be followed closely with FISH analyses, because some of the clonal chromosomal abnormalities may be early indicators of progression toward MDS-AML and thus also of the need for hematopoietic stem cell transplantation.
Journal ArticleDOI
Low dose decitabine in very high risk relapsed or refractory acute myeloid leukaemia in children and young adults
Christine L Phillips,Stella M. Davies,Richard McMasters,Michael J. Absalon,Maureen M. O'Brien,Jun Mo,Randall Broun,Jeffrey A. Moscow,Teresa A. Smolarek,Ramiro Garzon,William Blum,Sebastian Schwind,Guido Marcucci,John P. Perentesis +13 more
TL;DR: Low‐dose decitabine has encouraging activity and tolerability in adults with acute myeloid leukaemia (AML), but paediatric experience is lacking, and eight patients with refractory/relapsed AML are reported on.
Journal ArticleDOI
Translocation (8;18;16)(p11;q21;p13). A new variant of t(8;16)(p11;p13) in acute monoblastic leukemia: case report and review of the literature.
TL;DR: The patient with acute myeloid leukemia (AML) had typical clinical manifestation and bone marrow features of AML subtype M5b associated with t(8;16)(p11;p13) associated with AML M4/M5, and it is believed that the t( 8;18;16) is a new variant of t
Journal ArticleDOI
Prevalence and Clinical Characterization of CD20 and CD22 Expression in Pediatric Precursor B-Cell Acute Lymphoblastic Leukemia
Melissa Rayburg,Daniel Marmer,Jun Mo,Richard McMasters,Teresa A. Smolarek,Beatrice Lampkin,John P. Perentesis +6 more
TL;DR: Jeha et al. as mentioned in this paper found that CD22 was expressed at high levels (68-99%) in all patients evaluated, while CD20 expression was positive in 27 (54%) of patients.
Journal Article
Prevalence and clinical characterization of cd20 and cd22 expression in pediatric precursor b-cell acute lymphoblastic leukemia
Melissa Rayburg,Daniel Marmer,Jun Mo,Richard McMasters,Teresa A. Smolarek,Beatrice Lampkin,John P. Perentesis +6 more
TL;DR: The findings of frequent expression of CD22 on precursor-B ALL blasts from children supports its consideration as a target for immunotherapy approaches in high risk or relapsed disease.